(Q41744540)

English

Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death

scientific article published on 19 September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Newcastle disease

1 reference

based on heuristic

inferred from title

Abhishek D. Garg

2

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Steven De Vleeschouwer

7

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Patrizia Agostinis

8

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

object named as

Matteo Riva

4

0 references

object named as

Norbert Graf

9

0 references

Lien Vandenberk

5

object named as

Lien Vandenberk

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Stefaan Van Gool

10

object named as

Stefaan W Van Gool

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

6

object named as

Louis Boon

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Carolien A M Koks

1

object named as

Carolien A Koks

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

author name string

Michael Ehrhardt

3

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

language of work or name

0 references

publication date

19 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

136

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

E313-25

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

The 2007 WHO classification of tumours of the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Oncolytic virotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Safety and clinical usage of newcastle disease virus in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Efficacy and safety/toxicity study of recombinant vaccinia virus JX-594 in two immunocompetent animal models of glioma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Immunogenic cell death and DAMPs in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Immunogenic cell death in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Measles virus causes immunogenic cell death in human melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Autophagy regulation by nutrient signaling

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Molecular mechanisms of ATP secretion during immunogenic cell death

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

AMPK -> ULK1 -> autophagy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Respiration and ATP Level in BHK21/13S Cells during the Earliest Stages of Rubella Virus Replication

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Visualization and measurement of ATP levels in living cells replicating hepatitis C virus genome RNA.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Rep protein of tomato yellow leaf curl geminivirus has an ATPase activity required for viral DNA replication.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Activation of the ATPase activity of adeno-associated virus Rep68 and Rep78.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

TRAIL is involved in the tumoricidal activity of mouse natural killer cells stimulated by Newcastle disease virus in vitro

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29202

21 January 2018

Identifiers

10.1002/IJC.29202

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41744540&oldid=1927261744"